Two Sigma Advisers
TMCI icon

Two Sigma Advisers’s Treace Medical Concepts TMCI Stock Holding History

Two Sigma Advisers’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-32,200
Closed -$270K – 2544
2025
Q1 		$270K Sell
32,200
-15,700
-33% -$141K ﹤0.01% 2026
2024
Q4 		$356K Buy
47,900
+14,900
+45% +$99.7K ﹤0.01% 1905
2024
Q3 		$191K Sell
33,000
-40,100
-55% -$258K ﹤0.01% 2081
2024
Q2 		$486K Buy
73,100
+42,500
+139% +$343K ﹤0.01% 1893
2024
Q1 		$399K Buy
+30,600
New +$408K ﹤0.01% 1958
2023
Q4 		– Sell
-19,100
Closed -$250K – 2644
2023
Q3 		$250K Sell
19,100
-42,400
-69% -$776K ﹤0.01% 2036
2023
Q2 		$1.57M Buy
61,500
+38,700
+170% +$999K ﹤0.01% 1325
2023
Q1 		$574K Buy
+22,800
New +$535K ﹤0.01% 1886

Other funds holding TMCI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Two Sigma Advisers's TMCI Position: Q2 2025 in Review

Two Sigma Advisers sold out of Treace Medical Concepts (TMCI) in Q2 2025, closing a stake of 32,200 shares — an estimated $270K sold.

Two Sigma Advisers first reported a position in TMCI in Q1 2023 and held it in 8 quarters. The position peaked at $1.57M in Q2 2023. 125 funds tracked by Wall St. Rank hold TMCI as of Q2 2025.

  • Two Sigma Advisers reported no remaining Treace Medical Concepts position as of Q2 2025 after selling out during the quarter.
  • Two Sigma Advisers sold 32,200 Treace Medical Concepts shares in Q2 2025, an estimated $270K.
  • Two Sigma Advisers first reported a position in Treace Medical Concepts in Q1 2023 and held it in 8 quarters.
  • Two Sigma Advisers's Treace Medical Concepts position peaked at $1.57M in Q2 2023.
  • 125 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2025.

Based on Two Sigma Advisers's 13F filing for Q2 2025, filed 14 Aug 2025.